These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 14807907)

  • 41. XIII. Thromboangiitis obliterans (Buerger's disease).
    WEBER FP
    Practitioner; 1956 Feb; 176(1052):212-5. PubMed ID: 13310400
    [No Abstract]   [Full Text] [Related]  

  • 42. [Winiwarter-Buerger's disease (thromboangiitis obliterans)].
    KODEJSZKO E
    Pol Tyg Lek (Wars); 1950 Apr; 5(16):625-8; concl. PubMed ID: 14776065
    [No Abstract]   [Full Text] [Related]  

  • 43. [Winiwarter-Buerger's disease (thromboangiitis obliterans)].
    KODEJSZKO E
    Pol Tyg Lek (Wars); 1950 Apr; 5(15):568-73; contd. PubMed ID: 14776053
    [No Abstract]   [Full Text] [Related]  

  • 44. Thromboangiitis obliterans (Buerger's disease) with intestinal involvement--a case report.
    Núñez Garcia A; López Cubero L; Rico Zalba L; Molíns Otero A; Gómez Octavio J; Arribas A
    Angiology; 1998 Jun; 49(6):489-92. PubMed ID: 9631896
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Buerger's disease and anticardiolipin antibodies.
    Pereira de Godoy JM; Braile DM
    J Cardiovasc Med (Hagerstown); 2009 Oct; 10(10):792-4. PubMed ID: 19455050
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Pathogenic therapy of thromboangiitis obliterans (Buerger's disease)].
    NIKOLAKOV P
    Khirurgiia (Sofiia); 1959; 12(1):31-4. PubMed ID: 13642592
    [No Abstract]   [Full Text] [Related]  

  • 47. [Contribution to diagnosis and therapy of thromboangiitis obliterans (Buerger's)].
    DRAGOJEVIC B; NACEV S; TOFOVIC P
    Med Arh; 1959; 12():5-16. PubMed ID: 13817965
    [No Abstract]   [Full Text] [Related]  

  • 48. [Thromboangiitis obliterans (Buerger's disease) with visceral localization].
    GJØRUP PA
    Nord Med; 1954 Sep; 52(37):1274-6. PubMed ID: 13203821
    [No Abstract]   [Full Text] [Related]  

  • 49. Painful digital infarction in a male smoker treated as Buerger's disease.
    Foley S; Gibbs H; Muir J
    Australas J Dermatol; 2008 May; 49(2):94-7. PubMed ID: 18412809
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Successful Percutaneous Transcatheter Angioplasty of Radial Artery in Thromboangiitis Obliterans (Buerger's Disease).
    Taniguchi T; Higuchi T; Tazaki J; Saito N; Kimura T
    JACC Cardiovasc Interv; 2017 Nov; 10(22):e205-e206. PubMed ID: 28917511
    [No Abstract]   [Full Text] [Related]  

  • 51. [Buerger's thromboangiitis obliterans causing gastrointestinal disease].
    SORENSEN KH
    Nord Med; 1956 Sep; 56(37):1340-3. PubMed ID: 13378705
    [No Abstract]   [Full Text] [Related]  

  • 52. Surgical sympathectomy for Buerger's disease.
    Cacione DG; Moreno DH; Nakano LC; Baptista-Silva JC
    JRSM Open; 2017 Aug; 8(8):2054270417717666. PubMed ID: 28811905
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Generalized Winiwarter-Buerger's thromboangiitis obliterans in a woman 39-years of age].
    KARPISEK J; NEMECEK J; VALACH V
    Cas Lek Cesk; 1951 Aug; 90(33):997-1001. PubMed ID: 14859284
    [No Abstract]   [Full Text] [Related]  

  • 54. Buerger's disease revisited.
    Welling RE
    Angiology; 1982 Apr; 33(4):239-50. PubMed ID: 7073017
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A randomized trial of intravenous iloprost (a stable prostacyclin analogue) versus lumbar sympathectomy in the management of Buerger's disease.
    Bozkurt AK; Köksal C; Demirbas MY; Erdoğan A; Rahman A; Demirkiliç U; Ustünsoy H; Metin G; Yillik L; Onol H; Cinar B; Karaçelik M; Erdinç I; Bolcal C; Sayin AG;
    Int Angiol; 2006 Jun; 25(2):162-8. PubMed ID: 16763533
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The prostacyclin analog, treprostinil sodium, provides symptom relief in severe Buerger's disease--a case report and review of literature.
    Fernandez B; Strootman D
    Angiology; 2006; 57(1):99-102. PubMed ID: 16444463
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Thromboangiitis obliterans (Buerger's disease): searching for a therapeutic strategy.
    Paraskevas KI; Liapis CD; Briana DD; Mikhailidis DP
    Angiology; 2007; 58(1):75-84. PubMed ID: 17351161
    [TBL] [Abstract][Full Text] [Related]  

  • 58. An Iranian scoring system for diagnosing Buerger's disease.
    Ramin M; Salimi J; Meysamie A
    Acta Med Iran; 2014 Feb; 52(1):60-5. PubMed ID: 24658990
    [TBL] [Abstract][Full Text] [Related]  

  • 59. THROMBOANGIITIS OBLITERANS: THE CASE FOR BUERGER'S DISEASE.
    LUTTWAK EM; EYAL Z
    Isr Med J; 1963; 22():33-9. PubMed ID: 14078535
    [No Abstract]   [Full Text] [Related]  

  • 60. Serotonin as a factor involved in pathophysiology of thromboangiitis obliterans.
    Pietraszek MH; Choudhury NA; Baba S; Sakaguchi S; Hachiya T; Urano T; Takada Y; Takada A
    Int Angiol; 1993 Mar; 12(1):9-12. PubMed ID: 8376917
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.